GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » EV-to-EBIT

PT Jayamas Medica Industri Tbk (ISX:OMED) EV-to-EBIT : 12.12 (As of May. 10, 2024)


View and export this data going back to 2022. Start your Free Trial

What is PT Jayamas Medica Industri Tbk EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PT Jayamas Medica Industri Tbk's Enterprise Value is Rp4,362,662 Mil. PT Jayamas Medica Industri Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was Rp359,897 Mil. Therefore, PT Jayamas Medica Industri Tbk's EV-to-EBIT for today is 12.12.

The historical rank and industry rank for PT Jayamas Medica Industri Tbk's EV-to-EBIT or its related term are showing as below:

ISX:OMED' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.75   Med: 12.55   Max: 27.65
Current: 12.07

During the past 5 years, the highest EV-to-EBIT of PT Jayamas Medica Industri Tbk was 27.65. The lowest was 9.75. And the median was 12.55.

ISX:OMED's EV-to-EBIT is ranked better than
71.55% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.81 vs ISX:OMED: 12.07

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PT Jayamas Medica Industri Tbk's Enterprise Value for the quarter that ended in Mar. 2024 was Rp4,343,249 Mil. PT Jayamas Medica Industri Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was Rp359,897 Mil. PT Jayamas Medica Industri Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.29%.


PT Jayamas Medica Industri Tbk EV-to-EBIT Historical Data

The historical data trend for PT Jayamas Medica Industri Tbk's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Jayamas Medica Industri Tbk EV-to-EBIT Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - 11.79 13.96

PT Jayamas Medica Industri Tbk Quarterly Data
Dec19 Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.51 11.59 12.80 13.96 12.07

Competitive Comparison of PT Jayamas Medica Industri Tbk's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Jayamas Medica Industri Tbk's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Jayamas Medica Industri Tbk's EV-to-EBIT falls into.



PT Jayamas Medica Industri Tbk EV-to-EBIT Calculation

PT Jayamas Medica Industri Tbk's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4362662.231/359896.565
=12.12

PT Jayamas Medica Industri Tbk's current Enterprise Value is Rp4,362,662 Mil.
PT Jayamas Medica Industri Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp359,897 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Jayamas Medica Industri Tbk  (ISX:OMED) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PT Jayamas Medica Industri Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=359896.565/4343249.412
=8.29 %

PT Jayamas Medica Industri Tbk's Enterprise Value for the quarter that ended in Mar. 2024 was Rp4,343,249 Mil.
PT Jayamas Medica Industri Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp359,897 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Jayamas Medica Industri Tbk EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PT Jayamas Medica Industri Tbk's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Jayamas Medica Industri Tbk (ISX:OMED) Business Description

Traded in Other Exchanges
N/A
Address
Sebelah Selatan Jalan By Pass RT 05 / RW 01, Kelurahan Sidomojo, Kecamatan Krian, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing medical devices and other household health supplies. It initially began with the manufacture of urine bags, OneMed later expanded in the manufacturing business of medical equipment and supplies in Indonesia with a range of variants of products manufactured locally. The Company and its Subsidiaries has three main divisions: Manufacturing; Distribution and Retail.

PT Jayamas Medica Industri Tbk (ISX:OMED) Headlines

From GuruFocus

OncoMed Announces Publication of Phase 1a Data of Navicixizumab

By Marketwired Marketwired 09-24-2018

Tumor Drug Takes The Focus At OncoMed Pharmaceuticals

By reports.droy reports.droy 01-29-2015